Daily Stock Ratings & Price Targets

Daily stock ratings from over 8,000 Wall Street analysts

Analyst Top Stocks

Top Smart Score Stocks

AI Analyst Top Stocks

Trending Stocks

Stock Screener

Daily Analyst Ratings

Penny Stocks Screener

Insider Hot Stocks

Daily Buy Ratings

Analyst & Firm	Company	Rating & Price Target	Upside / Downside
Thomas Chong Jefferies	9988 Alibaba Group Holding Ltd.	BUYHK$179	42.63% Upside
Carole Madjo Barclays	1913 Prada SpA	BUYHK$68	75.71% Upside
Eunice Lee Bernstein	0175 Geely Automobile Holdings	BUYHK$22	-10.79% Downside
Neil Beveridge Bernstein	1211 BYD Co	BUYHK$136	31.78% Upside

Daily Sell Ratings

Analyst & Firm	Company	Rating & Price Target	Upside / Downside
Jason Sum DBS	0670 China Eastern Airlines Corporation Limited Class H	SELLHK$2.9	-25.64% Downside
Jason Sum DBS	1055 China Southern Airlines Company Limited Class H	SELLHK$3.4	-18.66% Downside
Jason Sum DBS	0753 Air China	SELLHK$4.1	-17.51% Downside

Full List of Stock Ratings

(Apr 10, 2026)

Analyst Performance

Any

Analyst Rating

Any

Upside / Downside

Any

Action

Any

Market Cap

Any

Analyst & Firm	Company	Rating & Price Target	Upside / Downside	Average Return	Action	Date	Article
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD HK$14.2	―	6.20%	Reiterated	2026-04-10
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY HK$43	―	9.80%	Reiterated	2026-04-10
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	SELL HK$4.1	―	23.40%	Reiterated	2026-04-09
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	SELL HK$3.4	―	23.40%	Reiterated	2026-04-09
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	SELL HK$2.9	―	23.40%	Reiterated	2026-04-09
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY HK$26	―	24.60%	Reiterated	2026-04-09
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY HK$68	―	0.60%	Reiterated	2026-04-09
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY HK$6.2	―	20.50%	Reiterated	2026-04-09
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY HK$58	―	19.10%	Reiterated	2026-04-09
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY HK$206→HK$179	―	11.00%	Reiterated	2026-04-09
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY HK$102	―	9.90%	Reiterated	2026-04-09
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY HK$6.9	―	0.80%	Reiterated	2026-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY HK$78	―	3.40%	Reiterated	2026-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY HK$42	―	15.20%	Reiterated	2026-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY HK$52→HK$46	―	8.00%	Reiterated	2026-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY HK$62.6	―	6.20%	Reiterated	2026-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD HK$15	―	7.10%	Downgraded	2026-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY HK$136	―	3.40%	Reiterated	2026-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY HK$46	―	5.50%	Reiterated	2026-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY HK$22	―	5.50%	Reiterated	2026-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD ―	―	4.10%	Assigned	2026-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY HK$95→HK$89	―	0.80%	Reiterated	2026-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY HK$26.2→HK$32	―	15.90%	Reiterated	2026-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY HK$109	―	0.80%	Reiterated	2026-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY HK$20.5	―	9.00%	Reiterated	2026-04-08
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY HK$17.7	―	38.50%	Reiterated	2026-04-08
Gary Yu Morgan Stanley	0700 Tencent Holdings	BUY HK$650	―	-1.70%	Reiterated	2026-04-07	Morgan Stanley Reaffirms Their Buy Rating on Tencent Holdings (TCTZF)
Laurence Tam Morgan Stanley	2269 Wuxi Biologics (Cayman)	BUY HK$50	―	-5.30%	Reiterated	2026-04-07	Analysts Offer Insights on Healthcare Companies: Wuxi Biologics (Cayman) (Other OTC: WXIBF) and Alkermes (NASDAQ: ALKS)

Rows:

Ready for the Full Picture?Your current plan limits your access to top-tier analyst ratings. Subscribe to Premium now and unlock the full range of ratings from the highest-ranked analysts on Wall Street. Don't let partial views limit your market research potential - upgrade today!

Upgrade Now Plans & Pricing